|
MAP9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.804340E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.357400E-04 |
| Normal-vs-Stage2 |
6.310400E-01 |
| Normal-vs-Stage3 |
9.690300E-02 |
| Normal-vs-Stage4 |
6.824400E-01 |
| Stage1-vs-Stage2 |
2.508800E-01 |
| Stage1-vs-Stage3 |
6.522400E-01 |
| Stage1-vs-Stage4 |
4.287400E-01 |
| Stage2-vs-Stage3 |
5.602000E-01 |
| Stage2-vs-Stage4 |
9.565200E-01 |
| Stage3-vs-Stage4 |
6.720200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.820640E-04 |
| Normal-vs-AfricanAmerican |
5.774200E-02 |
| Normal-vs-Asian |
3.230100E-04 |
| Caucasian-vs-AfricanAmerican |
4.379600E-01 |
| Caucasian-vs-Asian |
5.481500E-02 |
| AfricanAmerican-vs-Asian |
2.886100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07419999995084E-06 |
| Normal-vs-Female |
7.745000E-01 |
| Male-vs-Female |
1.744340E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.218180E-02 |
| Normal-vs-Extreme_Weight |
4.34550000000256E-05 |
| Normal-vs-Obese |
1.254220E-01 |
| Normal-vs-Extreme_Obese |
2.426200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.246800E-01 |
| Normal_Weight-vs-Obese |
3.932000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.734600E-01 |
| Extreme_Weight-vs-Obese |
4.552400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.073800E-01 |
| Obese-vs-Extreme_Obese |
8.157200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.842000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.308560E-01 |
| Normal-vs-Age(61-80Yrs) |
1.58400000005443E-06 |
| Normal-vs-Age(81-100Yrs) |
3.67500000000298E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.094200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.098400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.247700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.900100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.926100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.275000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.180200E-03 |
| Normal-VS-Type2 PRCC |
6.89309999968302E-07 |
| Normal-VS-KIRP CIMP |
2.619200E-01 |
| Normal-VS-Unclassified PRCC |
6.326000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.049600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.138200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.543580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.620400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.564400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.206400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53540999999757E-05 |
| Normal-vs-N1 |
3.641200E-01 |
| Normal-vs-N2 |
8.728100E-02 |
| N0-vs-N1 |
8.821700E-02 |
| N0-vs-N2 |
7.039600E-01 |
| N1-vs-N2 |
6.324600E-01 |
|
|
